Back

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: pro.

26 August 2022 (11:15 - 11:30)
Organised by:
Congress Presentation Part of: Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

2 More presentations in this session

Presentation thumbnail
Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: con.
Professor C. Baigent (Oxford, GB)
Slides Video
Presentation thumbnail
Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers – the final word.
Video

Access the full session

Session thumbnail
Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture in lipid lowering therapy and the atheroma .
26 August 2022
thumbnail
Congress Presentation
Imaging in cardiovascular disease prevention: focus on CT
26 April 2024
thumbnail
Congress Session
Daily Highlights Programme - Asian Pacific Society of Cardiology
28 August 2022
thumbnail
Congress Presentation
Personalised lipid-lowering therapy in different patient populations
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources